• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problem Insufficient Information (3190)
Patient Problem Stroke/CVA (1770)
Event Date 10/28/2022
Event Type  Injury  
Event Description
The manufacturer was informed of the following event through mantra study.The patient went under aortic valve replacement on (b)(6) 2022 due to degeneration and perceval sutureless aortic heart valve pvs25 was implanted in the patient through median sternotomy.The concomitant procedure was cabg.Reportedly, patient had moderate stroke with hemisindrom and epilepsy on (b)(6) 2022.Based on the information received, action taken was adding medications as well as performing diagnostic examinations and/or tests.Patient was nyha class iii.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve and nitinol stent, model #icv1210, s/n # (b)(4), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve and its component satisfied all material, visual, and performance standards required for a model #icv1210 perceval heart valve at the time of manufacture and release.Device remained implanted.
 
Event Description
The manufacturer was informed of the following event through mantra study.The patient went under aortic valve replacement on (b)(6) 2022 due to degeneration and perceval sutureless aortic heart valve pvs25 was implanted in the patient through median sternotomy.The concomitant procedure was cabg.Reportedly, patient had moderate stroke with hemosiderin and epilepsy on (b)(6) 2022.Based on the information received, action taken was adding medications as well as performing diagnostic examinations and/or tests.Patient was nyha class iii.Patient has a history of hypertension, diabetes mellitus, dyslipidemia, and tobacco use.Based on the information available, examination was performed on the patient.Reportedly, soft cortical-subcortical blurring in the right pericentral area, possibly of a recent ischemic nature was seen.Reportedly, it was not possible to exclude changes of a peri-postcritical nature.Regular amplitude of the ventricular system with increased amplitude of the peripheral csf spaces were noted.No further information is available at this time.
 
Manufacturer Narrative
Since the device remained implanted in the patient and there is no induction of device being explanted, further investigation on the actual device cannot be performed.Based on the information available, it is not possible to establish a definitive root cause of the reported event.However, from the document review performed, no manufacturing deficiencies were identified.It is possible that patient clinical history and risk factors (i.E., hypertension, diabetes mellitus, dyslipidemia, tobacco history) has contributed to the reported event.Ultimately, since the device was not returned to the manufacturer for further investigation, this cannot be confirmed.Should any further information be received in the future, a follow up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc 
MDR Report Key15992447
MDR Text Key305585853
Report Number3004478276-2022-00213
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000436
UDI-Public(01)00896208000436(240)ICV1210(17)231202
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/02/2023
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/17/2022
Initial Date FDA Received12/15/2022
Supplement Dates Manufacturer Received01/27/2023
Supplement Dates FDA Received01/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/02/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age68 YR
Patient SexFemale
Patient Weight42 KG
-
-